4//SEC Filing
FUERST THOMAS RICHARD 4
Accession 0001144204-11-068436
CIK 0001326190other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 8:21 PM ET
Size
7.8 KB
Accession
0001144204-11-068436
Insider Transaction Report
Form 4
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
- Award
Stock Options (right to buy)
2011-12-01+29,545→ 29,545 totalExercise: $1.21Exp: 2021-12-01→ Common Stock (29,545 underlying) - Award
Stock Options (right to buy)
2011-12-01+75,000→ 75,000 totalExercise: $1.21Exp: 2021-12-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On December 1, 2011, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.21 per share.
- [F3]The options vest 100% on the first anniversary of the grant date.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001488331
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 8:21 PM ET
- Size
- 7.8 KB